↓ Skip to main content

Dove Medical Press

Review of levetiracetam, with a focus on the extended release formulation, as adjuvant therapy in controlling partial-onset seizures

Overview of attention for article published in Neuropsychiatric Disease and Treatment, September 2009
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (87th percentile)
  • Good Attention Score compared to outputs of the same age and source (71st percentile)

Mentioned by

twitter
1 X user
patent
2 patents
wikipedia
3 Wikipedia pages

Citations

dimensions_citation
34 Dimensions

Readers on

mendeley
66 Mendeley
Title
Review of levetiracetam, with a focus on the extended release formulation, as adjuvant therapy in controlling partial-onset seizures
Published in
Neuropsychiatric Disease and Treatment, September 2009
DOI 10.2147/ndt.s4844
Pubmed ID
Authors

Carol M Ulloa, Allen Towfigh, Joseph Safdieh

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 66 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Japan 1 2%
United States 1 2%
Argentina 1 2%
Belgium 1 2%
Unknown 62 94%

Demographic breakdown

Readers by professional status Count As %
Researcher 14 21%
Student > Ph. D. Student 12 18%
Professor > Associate Professor 6 9%
Student > Master 6 9%
Student > Postgraduate 5 8%
Other 12 18%
Unknown 11 17%
Readers by discipline Count As %
Medicine and Dentistry 23 35%
Agricultural and Biological Sciences 10 15%
Neuroscience 6 9%
Pharmacology, Toxicology and Pharmaceutical Science 4 6%
Chemistry 2 3%
Other 8 12%
Unknown 13 20%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 10. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 13 March 2021.
All research outputs
#3,415,054
of 25,373,627 outputs
Outputs from Neuropsychiatric Disease and Treatment
#493
of 3,132 outputs
Outputs of similar age
#11,612
of 102,318 outputs
Outputs of similar age from Neuropsychiatric Disease and Treatment
#2
of 7 outputs
Altmetric has tracked 25,373,627 research outputs across all sources so far. Compared to these this one has done well and is in the 86th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,132 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.6. This one has done well, scoring higher than 83% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 102,318 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 87% of its contemporaries.
We're also able to compare this research output to 7 others from the same source and published within six weeks on either side of this one. This one has scored higher than 5 of them.